department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

cenerimod · pharmadog

pharmadog
drugs
cenerimod

drug · small molecule

patient view →

cenerimod

Phase 3updated 2mo ago

by Idorsia Pharmaceutical Ltd🔗 ChEMBL

Phase 3

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.

indications

indications

Lupus

targets

Sphingosine 1-phosphate receptor 1

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

cenerimod

MOA

Sphingosine 1-phosphate receptor Edg-1 modulator

indication

Systemic Lupus Erythematosus

phase

phase_3

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 55m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying cenerimod

phase3A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatmentrecruitingn=300
phase3Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosusenrolling by invitationn=680
phase3A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosusactive not recruitingn=470
phase2A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)enrolling by invitationn=15
phase3A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosusactive not recruitingn=451
phase1A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participantscompletedn=6
phase2Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosuscompletedn=427
phase2Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosuscompletedn=105

more trials →